https://orcid.org/0000-0002-3829-7298
References
- Wasyanto T, Yasa A, Yudhistira Y. Cystatin C as a predictor of major adverse cardiovascular event in patients with acute myocardial infarction without cardiogenic shock and renal impairment after coronary intervention. Int J Gen Med. 2023;16:2219–2227. doi:10.2147/IJGM.S415595
- Zi M, Xu Y. Involvement of cystatin C in immunity and apoptosis. Immunol Lett. 2018;196:80–90. PMID: 29355583; PMCID: PMC7112947. doi:10.1016/j.imlet.2018.01.006
- Huo YX, Wei W, Liu Y, et al. Serum cystatin C levels are associated with obesity in adolescents aged 14–17 years. Front Endocrinol. 2022;13:816201. PMID: 35185798; PMCID: PMC8854751. doi:10.3389/fendo.2022.816201
- Karawajczyk M, Ramklint M, Larsson A. Reduced cystatin C-estimated GFR and increased creatinine-estimated GFR in comparison with iohexol-estimated GFR in a hyperthyroid patient: a case report. J Med Case Rep. 2008;2:66. PMID: 18307770; PMCID: PMC2268947. doi:10.1186/1752-1947-2-66
- Fricker M, Wiesli P, Brändle M, Schwegler B, Schmid C. Impact of thyroid dysfunction on serum cystatin C. Kidney Int. 2003;63(5):1944–1947. PMID: 12675875. doi:10.1046/j.1523-1755.2003.00925.x